N-(1-((1R,3R,4R,7S)-1-((Bis(4-methoxyphenyl)(phenyl)methoxy)methyl)-7-hydroxy-2,5-dioxabicyclo[2.2.1]heptan-3-yl)-5-methyl-2-oxo-1,2-dihydropyrimidin-4-yl)benzamide

95%

Reagent Code: #220262
fingerprint
CAS Number 445012-77-1

science Other reagents with same CAS 445012-77-1

blur_circular Chemical Specifications

scatter_plot Molecular Information
Weight 675.73 g/mol
Formula C₃₉H₃₇N₃O₈
inventory_2 Storage & Handling
Storage -20°C, Sealed, Drying, Inert Gas

description Product Description

Used as a key intermediate in the synthesis of antiviral agents, particularly in the development of nucleoside analogs for the treatment of hepatitis C and other RNA viral infections. Its structure enables selective modification of pharmacokinetic properties, enhancing bioavailability and metabolic stability in drug candidates. Commonly employed in prodrug strategies to improve cellular uptake and target specificity. Also utilized in research settings for exploring structure-activity relationships in pyrimidine-based therapeutics.

shopping_cart Available Sizes & Pricing

Size Availability Unit Price Quantity
inventory 100mg
10-20 days ฿4,380.00
inventory 250mg
10-20 days ฿7,420.00
inventory 1g
10-20 days ฿20,330.00
inventory 5g
10-20 days ฿95,190.00

Cart

No products

Subtotal: 0.00
Total 0.00 THB
Cart Checkout
N-(1-((1R,3R,4R,7S)-1-((Bis(4-methoxyphenyl)(phenyl)methoxy)methyl)-7-hydroxy-2,5-dioxabicyclo[2.2.1]heptan-3-yl)-5-methyl-2-oxo-1,2-dihydropyrimidin-4-yl)benzamide
No image available

Used as a key intermediate in the synthesis of antiviral agents, particularly in the development of nucleoside analogs for the treatment of hepatitis C and other RNA viral infections. Its structure enables selective modification of pharmacokinetic properties, enhancing bioavailability and metabolic stability in drug candidates. Commonly employed in prodrug strategies to improve cellular uptake and target specificity. Also utilized in research settings for exploring structure-activity relationships in pyr

Used as a key intermediate in the synthesis of antiviral agents, particularly in the development of nucleoside analogs for the treatment of hepatitis C and other RNA viral infections. Its structure enables selective modification of pharmacokinetic properties, enhancing bioavailability and metabolic stability in drug candidates. Commonly employed in prodrug strategies to improve cellular uptake and target specificity. Also utilized in research settings for exploring structure-activity relationships in pyrimidine-based therapeutics.

Mechanism -
Appearance -
Longevity -
Strength -
Storage -
Shelf Life -
Allergen(s) -
Dosage (Range) -
Recommended Dosage -
Dosage (Per Day) -
Recommended Dosage (Per Day) -
Mix Method -
Heat Resistance -
Stable in pH range -
Solubility -
Product Types -
INCI -

Purchase History for

Loading purchase history...